More specifically, it demonstrates how the affinity of the CAR T-cell to the tumour receptor modulates both its efficacy and resistance to the suppressive mechanisms of solid tumours.
Read moreA study coordinated by the Clínic-IDIBAPS and published in The Lancet Neurology, has examined the symptoms experienced by patients with anti-LGI1 encephalitis—a type of autoimmune encephalitis—af...
Read moreIt has been provided new scientific evidence that shows that problems with lung development in a fetus that grows below normal levels are related to vascular resistance.
Read moreEl proyecto RiTA (Enfermedades Vasculares PortoSinusoidales: Estratificación de Riesgos y Enfoques Terapéuticos, por sus siglas en inglés), que ha empezado en abril 2024, tiene como objetivo princi...
Read moreA clinical trial has demonstrated the potential of the amino acid L-serine, administered as an oral supplement, to improve the function of glutamate receptors in patients with GRINpathies.
Read moreA team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded through the Horizon 2020 programme, used their expertise and all they learnt in the colorectal and lung cancer scr...
Read moreResearchers at the Hospital Clínic-IDIBAPS have assessed the role of the immune system in patients with idiopathic pulmonary fibrosis (IPF) through three studies.
Read moreUn estudio demuestra que esta técnica mínimamente invasiva es segura y eficaz en la fase inicial de tumores del oído medio, y que disminuye el tiempo de hospitalización de los pacientes.
Read moreFunded by the European Union, META-BRAIN project presents an innovative approach to controlling brain activity by means of nanotechnology, with reduced magnetic field requirements, wireless capability...
Read moreThe project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow liver disease to be detected in the earliest stages, an...
Read moreThe combination of surgery with adjuvant immunotherapy, after surgery, was shown to improve disease-free survival rates in the last IMbrave 050 phase III study
Read morePublished in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key role in the progression of the disease.
Read more